Clinical Trials Logo
  1. Home
  2. Status Asthmaticus
  3. NCT02539420

A Prospective Trial of BiPAP Administration vs. Non-positive Pressure Therapy for Pediatric Status Asthmaticus

Status Asthmaticus Clinical Trial

Official title:
A Prospective, Randomized Trial of Early Versus Delayed BiPAP Administration or Non-positive Pressure Therapy in the Management of Pediatric Status Asthmaticus

Clinical Trial Summary

Though BiPAP is an increasingly common tool used by pediatric critical care physicians and there is promising data suggesting a role for BiPAP in the management of status asthmaticus, more information is needed to more definitively clarify the extent of its benefit, as well as when during an asthma exacerbation and in whom it is the most beneficial. In this study, which is among the first randomized studies of BiPAP use for status asthmaticus in the pediatric population, the investigators hope to better elucidate these issues to help guide clinicians' future management decisions.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02539420
Study type Interventional
Source Northwell Health
Contact
Status Withdrawn
Phase N/A
Start date April 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT02872597 - Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus Phase 1
Terminated NCT02966184 - Comparison of Albuterol for Status Asthmaticus Phase 4
Enrolling by invitation NCT00750568 - Intravenous Terbutaline in Severe Status Asthmaticus N/A
Completed NCT00124995 - Trial of Terbutaline for the Treatment of Status Asthmaticus in Children Phase 4
Recruiting NCT05819541 - Treating Exacerbations of Asthma With Oral Montelukast in Children Phase 2
Completed NCT01524198 - The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room Phase 2/Phase 3
Terminated NCT02780479 - Steroids in Children Hospitalized With Asthma Phase 4
Withdrawn NCT01403428 - Non Invasive Positive Pressure Ventilation in Status Asthmaticus Phase 2
Terminated NCT00683449 - Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma Phase 2
Withdrawn NCT03219736 - NiPPV in the Treatment of Acute Asthma Exacerbations N/A
Completed NCT00722020 - HFCWO in Hospitalized Asthmatic Children N/A
Withdrawn NCT03338205 - The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus Phase 3
Completed NCT02302261 - Pleth Variability and Asthma Severity in Children N/A
Recruiting NCT01770899 - Evaluation Montelukast in the Treatment of Status Asthmaticus N/A
Withdrawn NCT01188473 - Early Noninvasive Positive Pressure Ventilation in Children With Status Asthmaticus Phase 1
Withdrawn NCT04656587 - BPAP in Pediatric Asthma Pilot Study N/A
Completed NCT04929626 - Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus Phase 1
Completed NCT00623688 - Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital N/A
Recruiting NCT00491790 - Montelukast With Status Asthmaticus, Ages 2-5 Phase 2/Phase 3
Recruiting NCT00494572 - Montelukast With Status Asthmaticus, Ages 6-18 Phase 2/Phase 3